| Cash Flow | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|---|
| Net income | 17,087 | 12,443 | 10,467 | 8,503 |
| Depreciation | 7,623 | 3,867 | 3,129 | 2,526 |
| Amortization of intangible assets | 1,671 | 2,307 | 3,010 | 3,582 |
| Deferred income taxes | -917 | -1,637 | -2,139 | -2,167 |
| Stock-based compensation | 4,811 | 4,674 | 3,974 | 3,547 |
| Other, net | NaN | -667 | -720 | -661 |
| Gains from investments and other, net | 2,433 | NaN | NaN | NaN |
| Increase in trade receivables, net | 2,190 | 653 | 965 | 151 |
| Decrease in prepaid expenses and other assets | -2,179 | -266 | -542 | -317 |
| Decrease in accounts payable and other liabilities | -240 | -608 | -594 | -281 |
| Decrease in income taxes payable | -256 | -659 | -127 | -153 |
| Increase in deferred revenues from customer prepayments with significant financing component | 4,592 | NaN | NaN | NaN |
| Increase in deferred revenues | NaN | 154 | 656 | 781 |
| Increase in other deferred revenues | 50 | NaN | NaN | NaN |
| Net cash provided by operating activities | 31,977 | 20,821 | 18,673 | 17,165 |
| Purchases of marketable securities and other investments and acquisitions | 2,039 | 1,272 | 1,003 | 1,181 |
| Proceeds from sales and maturities of marketable securities and other investments | 5,848 | 776 | 572 | 1,113 |
| Acquisitions, net of cash acquired | NaN | 0 | 63 | 27,721 |
| Capital expenditures | 55,663 | 21,215 | 6,866 | 8,695 |
| Net cash used for investing activities | -51,854 | -21,711 | -7,360 | -36,484 |
| Proceeds from issuances of common stock | 1,449 | 653 | 742 | 1,192 |
| Payments for repurchases of common stock | 95 | 600 | 1,202 | 1,300 |
| Shares repurchased for tax withholdings upon vesting of restricted stock-based awards | 111 | 900 | 2,040 | 1,203 |
| Proceeds from issuances of mandatory convertible preferred stock, net of issuance costs | 4,954 | NaN | NaN | NaN |
| Payments of dividends to stockholders | 5,787 | 4,743 | 4,391 | 3,668 |
| (repayments of) proceeds from issuances of commercial paper, net | -2,285 | 1,889 | -167 | NaN |
| Proceeds from issuances of commercial paper, net of repayments | NaN | NaN | NaN | 500 |
| Proceeds from short-term financing related to capital expenditures, net | 3,345 | NaN | NaN | NaN |
| Proceeds from issuances of senior notes, term loan credit agreements and other borrowings, net of issuance costs | 46,093 | 19,548 | 0 | 33,494 |
| Repayments of senior notes, term loan credit agreements and other borrowings | 6,942 | 15,841 | 3,500 | 21,050 |
| Other financing activities, net | -337 | 1,092 | 4 | -55 |
| Net cash provided by (used for) financing activities | 40,284 | 1,098 | -10,554 | 7,910 |
| Effect of exchange rate changes on cash and cash equivalents | 96 | 124 | -70 | -209 |
| Net increase in cash and cash equivalents | 20,503 | 332 | 689 | -11,618 |
| Cash and cash equivalents at beginning of period | 10,786 | 10,454 | 9,765 | 21,383 |
| Cash and cash equivalents at end of period | 31,289 | 10,786 | 10,454 | 9,765 |
ORACLE CORP (ORCL)
ORACLE CORP (ORCL)